Definitive differentiation requires synovial fluid analysis: non-septic neutrophilic inflammation in multiple joints confirms immune-mediated polyarthritis (IMPA), while septic arthritis requires the combination of history, physical examination, and synovial fluid cytology plus culture for definitive diagnosis. Journal of the…+1
Differentiating IMPA from Septic Arthritis
Distribution pattern is the first clinical clue. IMPA is a polyarthropathy typically affecting the carpus and tarsus, whereas septic arthritis is typically a monoarthropathy of a larger, more proximal appendicular joint such as the elbow, hip, stifle, or hock. Journal of the… Preexisting osteoarthritis increases the risk of septic arthritis in any joint. Journal of the…
Radiographic findings help characterize but do not confirm either diagnosis. Septic arthritis produces secondary changes including increased soft tissue opacity within and surrounding the joint, osteophytosis, osteolysis, or mixed lytic and proliferative changes to the juxta-articular bone — critically, these bony changes affect all bones contributing to the joint, distinguishing septic arthritis from primary osteomyelitis or bony neoplasia. Journal of the… Erosive IMPA (e.g., rheumatoid arthritis, periosteal proliferative arthritis) is identified by subchondral bone lysis on radiographs; the non-erosive form shows no such changes. Journal of Smal…
Synovial fluid C-reactive protein (CRP) does not reliably separate the two conditions. Synovial CRP is significantly lower in osteoarthritis versus both IMPA and bacterial infective arthritis, making it useful for distinguishing inflammatory from non-inflammatory arthropathy — but synovial CRP does not differ significantly between IMPA and bacterial infective arthritis. Veterinary and… In IMPA cases, serum CRP is positively associated with synovial CRP, and synovial neutrophil count is positively associated with synovial CRP in both IMPA and bacterial infective arthritis groups. Veterinary and…
Serum CRP alone has only fair discriminatory potential between IMPA and steroid-responsive meningitis arteritis (SRMA), with an area under the ROC curve close to 0.7; it should not be used as the sole diagnostic modality for differentiating immune-mediated conditions. Frontiers in Ve…
Septic arthritis is most commonly caused by Staphylococcus spp, Streptococcus spp, and E. coli, arising via direct inoculation (trauma, surgery, penetrating wounds), hematogenous spread, or extension from nearby infection. MSD Vet Manuals Septic polyarthropathy can occur with hematogenous spread but is less common than monoarthropathy. Journal of the…
Before diagnosing non-associative (primary/idiopathic) IMPA, associative causes must be excluded. Associative IMPA is triggered by exogenous factors (vaccination, drugs) or endogenous extra-articular disorders including infections, neoplasia, inflammatory bowel disease, chronic hepatitis, and immune-mediated skin disease. Journal of Vete…+1 Associative IMPA may resolve with treatment of the underlying cause, making immunosuppression potentially unnecessary or even inappropriate. American Journa… Thoracic radiography and abdominal ultrasonography are commonly used in this workup, though their findings were not deemed useful toward overall case management in one cohort of 77 dogs with IMPA. American Journa…
Proteinuria is present in a substantial proportion of dogs with idiopathic non-erosive IMPA — prior reports placed the rate at 1–10% with urine protein:creatinine (UPC) less than 1 in all cases, though higher prevalence including severe proteinuria (UPC >2) has been reported. Journal of Smal… Proteinuria in this context typically resolves with treatment of the underlying IMPA. Journal of Smal…
Coagulation status in IMPA is predominantly normal. Viscoelastic testing at diagnosis shows 84.2% of dogs are normocoagulable, 10.5% hypocoagulable, 2.6% hypercoagulable, and 2.6% with mixed changes — in contrast to other systemic inflammatory disorders where coagulopathy is more common. Journal of Smal… Median age at IMPA diagnosis is 4 years (range 9 months to 10 years). Journal of Smal…
Treatment of IMPA
Corticosteroids are first-line immunosuppressive therapy for non-associative IMPA. Journal of Vete… Prednisolone alone is as effective as combination therapy, and efficacy between prednisolone and ciclosporin (cyclosporine) is similar. Journal of Vete… Adding leflunomide to corticosteroids has shown no significant benefit. Journal of Vete…
In large breeds, adding a second immunosuppressant early is recommended for faster steroid-sparing effects. Journal of Vete… Additional agents used include ciclosporin, mycophenolate mofetil, leflunomide, and azathioprine. Journal of Vete… No consensus exists on monotherapy versus combination therapy. Journal of Vete…
Response to therapy is favorable in 95% of dogs, though death is attributed to IMPA in 19% of dogs in one cohort. Journal of Smal… Complete cure (permanent withdrawal of immunosuppressive medication) is achieved in 63% of dogs overall — 74% of dogs started on multi-modal immunosuppression from the outset versus 59% started on corticosteroids alone. Journal of Smal… Overall, 81% of dogs have well-managed disease for an extended timeframe of at least 1,131 days. Journal of Smal…
Relapse is common and should be anticipated. Relapse rates are 43% at 6 months, 61% at 12 months, and 65% at 24 months, with a median time to relapse of 6.5 months. Journal of Vete… Remission is achieved in 95.8% of dogs. Journal of Vete… Lameness, lymphadenomegaly, and thrombocytosis at diagnosis are associated with a greater risk of relapse. Journal of Vete… Multiple relapses occur in 17 of 39 relapsing dogs. Journal of Smal…
For associative IMPA, treating the primary disease is the top priority — surgical or pharmacological — before or instead of immunosuppression. Journal of the… Reactive arthritis from some underlying causes (e.g., acute pancreatitis) may persist and require immunosuppressive treatment even after resolution of the primary cause. Journal of the…
| Feature | IMPA | Septic Arthritis |
|---|---|---|
| Joint distribution | Polyarthropathy; carpus and tarsus typical | Monoarthropathy; elbow, hip, stifle, hock typical |
| Radiographic bony changes | Erosive (subchondral lysis) or non-erosive | Lytic or mixed lytic/proliferative, all bones of joint affected |
| Synovial CRP | Elevated vs. OA; not different from septic | Elevated vs. OA; not different from IMPA |
| Synovial fluid | Non-septic neutrophilic inflammation, multiple joints | Cytology + culture required for definitive diagnosis |
| First-line treatment | Prednisolone (immunosuppression) | Antimicrobials targeting Staphylococcus, Streptococcus, E. coli |
| Remission rate | 95–95.8% | — |
| Relapse rate | 65% at 24 months | — |
Would you like guidance on prednisolone dosing protocols and tapering schedules for IMPA?